The Complexity of Being A20: From Biological Functions to Genetic Associations
- 7 March 2024
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (3) , 1-15
Abstract
A20, encoded by TNFAIP3, is a critical negative regulator of immune activation. A20 is a ubiquitin editing enzyme with multiple domains, each of which mediates or stabilizes a key ubiquitin modification. A20 targets diverse proteins that are involved in pleiotropic immunologic pathways. The complexity of A20-mediated immunomodulation is illustrated by the varied effects of A20 deletion in different cell types and disease models. Clinically, the importance of A20 is highlighted by its extensive associations with human disease. A20 germline variants are associated with a wide range of inflammatory diseases, while somatic mutations promote development of B cell lymphomas. More recently, the discovery of A20 haploinsufficiency (HA20) has provided real world evidence for the role of A20 in immune cell function. Originally described as an autosomal dominant form of Behcet’s disease, HA20 is now considered a complex inborn error of immunity with a broad spectrum of immunologic and clinical phenotypes.Keywords
Funding Information
- Jeffrey Modell Foundation
- Samuel and Emma Winters Foundation
This publication has 95 references indexed in Scilit:
- Resolving Incomplete Penetrance in Primary ImmunodeficienciesClinical Immunology, 2023
- The dual roles of A20 in cancerCancer Letters, 2021
- Polymorphisms in TNFAIP3, but not in STAT4, BANK1, BLK, and TNFSF4, are associated with susceptibility to Takayasu arteritisCellular Immunology, 2021
- Immunophenotyping of A20 haploinsufficiency by multicolor flow cytometryClinical Immunology, 2020
- Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human AutoantibodyCell, 2020
- Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatmentWorld Journal of Pediatrics, 2019
- Brief Report: Candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunityArthritis & Rheumatism, 2012
- The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents AutoimmunityImmunity, 2010
- The association of a nonsynonymous single‐nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese populationArthritis & Rheumatism, 2010
- The zinc finger protein A20 targets TRAF2 to the lysosomes for degradationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009